Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review
Solid–lipid nanoparticles and nanostructured lipid carriers are delivery systems for the delivery of drugs and other bioactives used in diagnosis, therapy, and treatment procedures. These nanocarriers may enhance the solubility and permeability of drugs, increase their bioavailability, and extend the residence time in the body, combining low toxicity with a targeted delivery. Nanostructured lipid carriers are the second generation of lipid nanoparticles differing from solid lipid nanoparticles in their composition matrix. The use of a liquid lipid together with a solid lipid in nanostructured lipid carrier allows it to load a higher amount of drug, enhance drug release properties, and increase its stability. Therefore, a direct comparison between solid lipid nanoparticles and nanostructured lipid carriers is needed. This review aims to describe solid lipid nanoparticles and nanostructured lipid carriers as drug delivery systems, comparing both, while systematically elucidating their production methodologies, physicochemical characterization, and in vitro and in vivo performance. In addition, the toxicity concerns of these systems are focused on.
Top-30
Journals
|
5
10
15
20
25
30
|
|
|
Pharmaceutics
26 publications, 9.56%
|
|
|
Journal of Drug Delivery Science and Technology
11 publications, 4.04%
|
|
|
International Journal of Pharmaceutics
8 publications, 2.94%
|
|
|
International Journal of Molecular Sciences
7 publications, 2.57%
|
|
|
AAPS PharmSciTech
7 publications, 2.57%
|
|
|
International Journal of Nanomedicine
7 publications, 2.57%
|
|
|
Expert Opinion on Drug Delivery
6 publications, 2.21%
|
|
|
Journal of Nanobiotechnology
6 publications, 2.21%
|
|
|
Molecules
5 publications, 1.84%
|
|
|
Naunyn-Schmiedeberg's Archives of Pharmacology
4 publications, 1.47%
|
|
|
Scientific Reports
4 publications, 1.47%
|
|
|
Nanomedicine
4 publications, 1.47%
|
|
|
Pharmaceuticals
3 publications, 1.1%
|
|
|
Frontiers in Pharmacology
3 publications, 1.1%
|
|
|
Colloids and Surfaces B: Biointerfaces
3 publications, 1.1%
|
|
|
Drug Development and Industrial Pharmacy
3 publications, 1.1%
|
|
|
BioNanoScience
3 publications, 1.1%
|
|
|
RSC Advances
3 publications, 1.1%
|
|
|
Current Pharmaceutical Design
3 publications, 1.1%
|
|
|
ACS Omega
2 publications, 0.74%
|
|
|
European Journal of Pharmaceutical Sciences
2 publications, 0.74%
|
|
|
Chinese Chemical Letters
2 publications, 0.74%
|
|
|
Analytical Chemistry Letters
2 publications, 0.74%
|
|
|
Gels
2 publications, 0.74%
|
|
|
Molecular Pharmaceutics
2 publications, 0.74%
|
|
|
Drug Delivery and Translational Research
2 publications, 0.74%
|
|
|
Antioxidants
2 publications, 0.74%
|
|
|
Cosmetics
2 publications, 0.74%
|
|
|
Cureus
2 publications, 0.74%
|
|
|
5
10
15
20
25
30
|
Publishers
|
10
20
30
40
50
60
70
80
|
|
|
Elsevier
74 publications, 27.21%
|
|
|
MDPI
62 publications, 22.79%
|
|
|
Springer Nature
49 publications, 18.01%
|
|
|
Taylor & Francis
31 publications, 11.4%
|
|
|
Bentham Science Publishers Ltd.
11 publications, 4.04%
|
|
|
Royal Society of Chemistry (RSC)
10 publications, 3.68%
|
|
|
American Chemical Society (ACS)
8 publications, 2.94%
|
|
|
Wiley
7 publications, 2.57%
|
|
|
Frontiers Media S.A.
5 publications, 1.84%
|
|
|
Hindawi Limited
2 publications, 0.74%
|
|
|
SAGE
2 publications, 0.74%
|
|
|
Research Square Platform LLC
1 publication, 0.37%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 0.37%
|
|
|
Beilstein-Institut
1 publication, 0.37%
|
|
|
SciELO
1 publication, 0.37%
|
|
|
Mary Ann Liebert
1 publication, 0.37%
|
|
|
Pensoft Publishers
1 publication, 0.37%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 0.37%
|
|
|
Naksh Solutions
1 publication, 0.37%
|
|
|
Emerald
1 publication, 0.37%
|
|
|
IntechOpen
1 publication, 0.37%
|
|
|
Alexandria University
1 publication, 0.37%
|
|
|
10
20
30
40
50
60
70
80
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.